Abbott Laboratories (ABT)
NYSE: ABT · IEX Real-Time Price · USD
107.53
+0.67 (0.63%)
At close: Apr 26, 2024, 4:00 PM
107.44
-0.09 (-0.08%)
After-hours: Apr 26, 2024, 7:12 PM EDT
Abbott Laboratories Employees
Abbott Laboratories had 114,000 employees on December 31, 2023. The number of employees decreased by 1,000 or -0.87% compared to the previous year.
Employees
114,000
Change (1Y)
-1,000
Growth (1Y)
-0.87%
Revenue / Employee
$351,833
Profits / Employee
$50,202
Market Cap
186.58B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
Dec 31, 2012 | 91,000 | 0 | - |
Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
Dec 31, 2005 | 59,735 | -865 | -1.43% |
Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
Dec 31, 2003 | 72,200 | 381 | 0.53% |
Dec 31, 2002 | 71,819 | 393 | 0.55% |
Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
Dec 31, 1999 | 57,100 | 864 | 1.54% |
Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
Dec 31, 1995 | 50,241 | 777 | 1.57% |
Dec 31, 1994 | 49,464 | -195 | -0.39% |
Dec 31, 1993 | 49,659 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Thermo Fisher | 122,000 |
AstraZeneca | 89,900 |
Pfizer | 88,000 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Danaher | 63,000 |
AbbVie | 50,000 |
Amgen | 26,700 |
ABT News
- 5 days ago - Should You Pick Abbott Stock At $105 After An Upbeat Q1? - Forbes
- 10 days ago - Abbott Labs Stock Falls as Q2 Guidance Outweighs Earnings Beat - Investopedia
- 10 days ago - Abbott beats estimates, reports a 2.2% rise in Q1 sales - Invezz
- 10 days ago - Abbott Labs Stock Is Slipping. Disappointing Guidance Trumps a Strong Quarter. - Barrons
- 10 days ago - Abbott Labs first-quarter results top estimates amid strong medical device sales - Market Watch
- 10 days ago - Abbott beats quarterly profit estimates on strong medical device sales - Reuters
- 10 days ago - Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges - PRNewsWire
- 12 days ago - After Nearly A 20% Rise In Six Months Will Abbott Stock See Higher Levels Post Q1? - Forbes